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ABSTRACT 
Objective: The present study was designed to investigate the effect of anti-diabetic activity of Achyranthes aspera on alloxan induced wistar rats. 
Methods: Diabetes was induced by administration of alloxan mono hydrate (150 mg/kg body weight i. p) to albino wistar rats. Diabetic rats were 
stabilized for four days and from fifth-day aqueous extract of A. aspera were administered at the dose of 250 mg/kg and 500 mg/kg for 45 days. 
Metformin 1 mg/kg was used as a standard. The effects of A. aspera and standard drug on following parameters was recorded-fasting blood glucose, 
glycogen, plasma insulin, glycosylated hemoglobin and protein were analyzed in blood samples. Glucose-6-phosphatase, Glucose-6 phosphate 
dehydrogenase, tissue protein, reduced glutathione, and lipid peroxide were estimated in liver tissues.  
Results: Our results collectively suggested that administration of aqueous extracts of A. aspera considerably lower the blood glucose level which was 
comparable to standard anti-diabetic drug metformin (1 mg). Also, the extract shows that considerable increase (p˂0.05) in glucokinase activity when 
compared to untreated diabetic rats. Lipid peroxidation and reduced glutathione (GSH) level were also studied and the A. aspera aqueous extract and 
metformin-treated groups shows that the significant (p ˂0.05) reduction in lipid peroxide and marked elevation in reduced glutathione levels.  
Conclusion: Aqueous extract of A. aspera possess anti-diabetic action in alloxan induced diabetic rats. 
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INTRODUCTION 
Diabetes is a syndrome characterized by disordered metabolism of 
carbohydrate, protein and lipid with abnormally high blood sugar 
(hyperglycemia) resulting from low levels of the hormone insulin 
with or without abnormal resistance to insulin’s effect [1]. Diabetes 
mellitus is considered as one of the five leading causes of death in 
the world. About 150 million people are suffering from diabetes 
worldwide, which is almost five times more than the estimates ten 
years ago and this may double by the year 2030. India leads the way 
with its largest number of diabetic subjects in any given country. It 
has been estimated that the number of diabetes in India is employed 
to increase 57.2 million by the year 2025 [2, 3].  
The prevalence of diabetes mellitus is expected to rise more rapidly in 
the future because of increasing obesity and reduced activity levels [4]. 
Recently, some medicinal plants have been reported to be useful in 
diabetes worldwide and have been used empirically as anti-diabetic 
and antihyperlipidemic remedies [5]. More than 400 plant species 
with hypoglycemic activity are available in the literature [6]. 
Achyranthes aspera is a common plant found in wastelands and 
agricultural fields. The plant is highly esteemed by traditional 
healers. A. aspera L. known by different names in India viz. Latjira in 
Hindi, Apamargah in Sanskrit, Apang in Bengali, Katalati in 
Malayalam, Nayurivi in Tamil, Uttaren in Telugu and Prickly-chaff 
flower plant in English [7]. Different parts of the plant have been 
used as an expectorant, stomach tonic, laxative, anthelmintic, 
diuretic, lithontriptic, sudorific, demulcent, anti-inflammatory and 
haematinic in indigenous medicine [8]. Nowadays many studies 
have been reported diverse actions of A. aspera e. g. antiviral [9], 
antibacterial activity [10, 11], antifertility [12], antidiabetic [13], 
positive inotropic effect, spasmolytic to smooth muscle [14], diuretic 
and purgative [15]. The major aim of the study is to prove the 
hypoglycemic activity of A. aspera leaf extract. Which is found to be 
futile with evidence base literature. The rationale of the present 
study is to find out the level of efficacy and potency of the leaf 
extract in accordance with hypoglycemic activity. The present study 
differ from other literature evidence in means of increased dose 
level of signifying the expected pharmacological activity along with 
the control population. The A. aspera leaves were investigated for its 
antidiabetic in vivo in Alloxan induced diabetic rat model and to 
compare the same with metformin, a standard hypoglycemic drug. 
MATERIALS AND METHODS 
Collection and authentication of the plant material  
The leaves of Achyranthes aspera were collected in the month of 
March 2010 from Tropical area of Western Ghats region of 
Coimbatore district. Coimbatore lies between 11 ° 00' N latitude and 
77 °00' E longitude. It covers an area of 246.8 km2
Preparation of plant extract 
. The plant was 
authenticated at the Botanical Survey of India (BSI), Southern circle 
Coimbatore, Tamil Nadu, India. Where the voucher specimens were 
deposited (Herbarium vouchers no BSI/SC/5/23/09-10/Tech-266). 
The samples were shade dried at room temperature experimental 
purpose. 
The collected plant leaf materials were dried and finely powdered 
with an electrical blender. 200 g of A. aspera coarse powder was 
taken and extracted with water. To one part of the material and four 
parts of water was added, boiled and reduced to one-third and the 
filtrate was evaporated to dryness. Paste form of the extract was 
obtained and its subjected to pre-clinical screening. The percentage 
yield of extract was 49 % w/v. 
Experimental animals 
Healthy adult wistar strain of albino rats of either sex, weighing 150-
200 g was used as experimental models. Animals were kept in well-
ventilated cages and fed with standard rat chow pellet obtained 
from Sai Durga Food and Feeds, Bangalore, India and water ad 
libitum. Animals were maintained under standard laboratory 
conditions (Temperature 24-28 °C, relative humidity 60-70%). All 
the studies were conducted according to the ethical guidelines of 
CPCSEA after obtaining the necessary clearance from the Committee 
(Approval No: NCP/IAEC/Ph. D/2010-001). 
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Alloxan induction 
Diabetes mellitus was induced in a batch of normoglycemic albino 
rats, starved for 12 h. 150 mg/kg body weight of alloxan 
monohydrate was dissolved in physiological saline and injected 
intraperitoneally (IP). This dose of alloxan produced persistent 
hyperglycemia after four days as revealed by the determination of 
glucose levels by the analysis of blood and urine samples [16]. 
Experimental design 
The rats were divided into five groups and each group comprising of 
six rats. 
Group I-Normal control 
Group II-Animals treated with alloxan monohydrate in normal 
saline at a dosage of 150 mg/kg body weight IP. 
Group III-Animals were treated as in Group II. After 4 days of 
diabetes-induction, treated with A. aspera aqueous extract 250 
mg/kg body weight, orally for 45 days. 
Group IV-Animals were treated as in Group II. After 4 days of 
diabetes-induction, treated with A. aspera aqueous extract 500 
mg/kg body weight orally for 45 days. 
Group V-Animals were treated as in Group II. After 4 days of 
diabetes-induction, treated with standard drug metformin 1 mg/kg 
body weight orally for 45 days. 
The parameters studied 
Fasting blood glucose by folin-Wu’s method [17], glycogen [18], 
plasma insulin [19], glycosylated hemoglobin (HbA1C) [20] and 
protein were analyzed in the blood sample.  
Glucokinase [21], Glucose-6-phosphatase [22], Glucose-6-phosphate 
dehydrogenase [23], tissue protein by Lowry’s method [24], 
Reduced glutathione (GSH) [25] and Lipid peroxide (LPO) [26] were 
estimated in liver tissues. 
Statistical analysis 
All the results were expressed as mean±SEM. The data were 
statistically analyzed by one-way analysis of variance (ANOVA) 
between plant extract treated groups and disease control group. P 
values<0.05 were considered as significant. 
RESULTS 
Diabetes mellitus was induced by intra peritoneal injection of 
alloxan monohydrate to all the group of animals except Group I 
(Normal control) that caused severe diabetes in rats. Table 1 
shows that the levels of blood sugar, glycosylated hemoglobin 
(HbA1C) and plasma insulin in diabetes-induced untreated as 
well as plant drug treated animals. Effect of aqueous extract of A. 
aspera in alloxan induced diabetic rats was evident from the 
results of Group III & IV (250 mg/kg bw & 500 mg/kg bw 
respectively). A. aspera at a dose of 500 mg/kg produced a 
significant (p<0.05) fall in blood sugar and glycosylated 
hemoglobin level in diabetic rats.  
Plasma insulin level that was decreased in disease control was 
found to be increased in plant extract treated group of rats 
(Group III & IV). Animals treated with the standard drug also 
shows that a significant reduction in the blood glucose level and 
HbA1C level compared to Group II (p<0.05). The level of liver 
glycogen was reduced in alloxanized diabetic Group II rats. 
Administration of test drug for 45 days caused significant 
(p<0.05) elevation in liver glycogen levels. 
 
Table 1: Effect of A. aspera extract on blood glucose, glycosylated hemoglobin (HbA1C) serum insulin and Glycogen levels of experimental 
animals 
S. No. Group Blood glucose  
(mg/dl) 




1 Normal  82.31±10.07 2.82±0.64 22.75±6.02 41.17±10.92 





172.44±31.53** 3.95±1.72** 16.72±6.01** 23.08±5.14** 
4. Diabetic+A. aspera (500 mg/kg)  91.53±12.32** 2.94±0.95** 23.62±6.96** 39.25±7.32** 
5 Diabetic+Metformin (1 mg/kg) 84.05±12.78** 3.25±0.98** 19.68±7.83** 41.01±8.48** 
Values are mean±SEM (n=6), *P<0.05. statistically significant when compared to Group II with Group I, **P<0.05 statistically significant when 
compared to Group III, IV & V with Group II. 
 
Table 2 shows the activity of glucokinase in the liver of both control 
and experimental groups of rats. Oral administration of A. aspera 
aqueous extract (250 mg/kg & 500 mg/kg bw) for 45 days 
significantly increases (p<0.05) glucokinase activity when compared 
to untreated diabetic rats. In group II, diabetic rats showed a 
profound increase in the activity of glucose-6-phosphatase. 
Administration of A. aspera plant extract were found to be effective 
in resuming (p<0.05) the activity of glucose-6-phosphatase. Glucose-
6-phosphate dehydrogenase is one of the important glucose 
oxidizing enzyme and it was found to be altered significantly 
(p<0.05) in diabetic untreated rats (Group II). Administration of 
aqueous plant extract was elevated in the activity of glucose-6-
phosphate dehydrogenase in a dose-dependent manner. The effect 
was also compared with the standard drug (Group V). Total tissue 
and serum protein shows that the significant variation between 
diabetic and A. aspera extract treated animals. The levels of protein 
decreased in untreated diabetic animals and resumed back to 
normal after oral administration of A. aspera plant extracts. 
  
Table 2: Effect of A. aspera extract on Glucokinase, Glucose-6-phosphate, Glucose-6-phosphodehydrogenase activity in experimental 
animals 








1 Normal  114.02±29.54  7.02±1.76  12.04±1.92 
2 Diabetic control  92.32±12.45*  14.92±2.13 * 7.91±1.08* 
3 Diabetic+A. aspera (250 mg/kg)  99.45±22.02**  9.82±3.13**  8.93±1.94** 
4  Diabetic+A. aspera (500 mg/kg)  113.92±29.75**  8.95±2.02**  11.73±2.44** 
5 Diabetic+Metformin (1 mg/kg)  108.15±21.58**  10.18±4.76** 7.93±1.13** 
Values are mean±SEM (n=6), *P<0.05. Statistically significant when compared to Group II with Group I, **P<0.05 statistically significant when 
compared to Group III, IV& V with Group II. 
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Table 3 shows that Lipid peroxide/lipid peroxidase (LPO) and 
reduced glutathione (GSH) levels were also studied to evaluate the 
antioxidant status in alloxan-induced untreated and treated animals. 
A. aspera and metformin-treated groups shows that significant 
(p<0.05) reduction in the lipid peroxide level and marked elevation 
in reduced glutathione levels. 
  
Table 3: Effect of A. aspera extract for 45 days on serum and tissue protein, reduced glutathione and lipid peroxide levels in experimental 
animals 
S. No.  
 
 Group  
 
Serum protein  
(mg/dl)  






1 Normal  38.13±9.44  16.13±2.44  42.42±9.54  0.92±0.67 
2  Diabetic control  28.24±9.92*  11.23±2.78*  24.31±6.54*  1.95±0.14* 
3 Diabetic+A. aspera (250 mg/kg)  33.52±10.41**  11.33±1.54**  29.68±6.24**  1.51±0.56** 
4  Diabetic+A. aspera (500 mg/kg)  43.38±8.16**  14.81±1.84**  37.60±5.03**  1.82±0.12** 
5 Diabetic+Metformin (1 mg/kg)  39.82±5.26** 14.93±2.07**  39.41±7.98**  1.32±0.19** 
Values are mean±SEM (n=6), *P<0.05 statistically significant when compared to Group II with Group I, **P<0.05 statistically significant when 
compared to Group III, IV & V with Group II. 
 
DISCUSSION 
Since there are some clinical limitations and demerits with the 
currently available treatment regimens for diabetes mellitus, there is a 
requirement for safer and more potent Anti-diabetic drugs [27, 28]. 
Alloxan-induced Diabetes is associated with the specific dysfunction in 
the metabolic index. The liver plays a vital role in the maintenance of 
blood glucose level and hence it is of interest to evaluate the possible 
role of A. aspera on key enzymes of carbohydrate metabolism in the 
liver. The liver is the main site for glycolysis, a process where glucose 
is oxidized and gluconeogenesis, a process where glucose is 
synthesized from noncarbohydrate sources [29].  
The glucokinase activity was decreased in diabetic Group II rat. This 
may be due to insulin deficiency. Treatment with aqueous extract of 
A. aspera elevated the activity of glucokinase in the liver. A. aspera 
may stimulate insulin secretion, which activates glucokinase, 
thereby enhances the utilization of glucose leading to the profound 
decrease in blood glucose levels (Group III & IV) (table 1). 
Insulin decreases gluconeogenesis by decreasing the activity of the 
key enzyme, glucose-6-phosphatase [30]. In A. aspera treated rats, 
the activity of enzyme glucose-6-phosphatase was seen significantly 
reduced in the liver. This may be due to increased insulin secretion, 
which is responsible for the repression of one of the gluconeogenic 
key enzyme. 
The regulation of glycogen metabolism in vivo occurs by the 
multifunctional enzyme glycogen synthase and glycogen 
phosphorylase plays a major role in the glycogen metabolism. The 
reduced glycogen stored in diabetic rats has been attributed to 
reduced activity of glycogen synthase [31] and increased activity of 
glycogen phosphorylase [32]. Treatment with A. aspera elevated the 
activity of glycogen synthesis enzymes in the liver. 
The observed increase in the level of glycosylated hemoglobin 
(HbA1C) in the diabetic control group of rats is due to the presence 
of an excessive amount of blood glucose. Mechanisms by which 
increased oxidative stress is involved in the diabetic complications 
are partially known, including activation of transcription factors 
advanced glycation end product (AGEs) and protein kinase C. 
Glycosylated hemoglobin has been found to be increased over a long 
period of time in the diabetic mellitus [33]. There is an evidence that 
glycation may itself induces the generation of oxygen-derived free 
radicals in diabetic conditions. Treatment with A. aspera extract 
showed a significant decrease in the glycosylated hemoglobin with a 
concomitant increase in the level of total hemoglobin in diabetic rats. 
Animals, which is received standard drug metformin, also shows that 
the similar result. Reduced glutathione is a potent-free radical 
scavenger GSH within the islet of β-cell and is an important factor 
against the progressive destruction. Depletion of GSH results in 
enhanced lipid peroxidation (table 3). 
This can cause increased GSH consumption and can be correlated to 
the increase in the level of oxidized glutathione (GSH). Treatment of 
A. aspera resulted in the elevation of the GSH levels, which protect 
the cell membrane against oxidative damage by regulating the redox 
status of protein in the membrane [34]. 
In the present study reveals that the diabetic animals are exposed to 
oxidative stress and A. aspera can partially reduce the imbalances 
between the generation of reactive oxygen species (ROS) and the 
scavenging enzyme activity. According to these results, A. aspera 
could be a supplement, as an antioxidant therapy and may be useful 
for treating the hyperglycemia and preventing further diabetic 
complications. The A. aspera plants possess a significant 
hypoglycemic effect and it also controls the antioxidant level. 
CONCLUSION 
A lot of traditional Indian medicinal plants are used for treating 
various diseases and ailments which greatly focuses herbal 
medicines and herbal research into a spotlight. The present study 
estimated the Anti-diabetic effect of A. aspera. Further investigations 
are needed to quantify the mechanism of action of A. aspera in the 
treatment of hyperglycemic individuals with respect to its liver 
metabolic index and parameters. 
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